Stay updated on Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page.

Latest updates to the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has been updated to include new facility and drug information, as well as a list of publications related to a phase 1 trial of a CAR-T therapy for multiple myeloma. Notably, several previous terms and topics related to multiple myeloma and immunologic factors have been removed.SummaryDifference7%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page.